Abstract: A method for preventing surgical adhesion between surfaces that are to be prevented uses a blood product having fibrin. The blood product can be a singled layered blood product having components from plasma, components added to initiate a coagulation process, and components created during the coagulation process. The products and methods can be used for preventing surgical adhesion, for stopping or reducing bleeding in an open surgical wound, and for treating surgical wounds.
Type:
Application
Filed:
October 21, 2021
Publication date:
January 4, 2024
Applicant:
REAPPLIX A/S
Inventors:
Rasmus LUNDQUIST, Niels Erik HOLM, Morten Rosenberg ESKILDSEN
Abstract: A method for stopping or reducing bleeding in open surgical wounds uses blood product that has a first layer, and a second layer. The first layer is adjacent to the second layer and defines a first outer surface of the blood product. The first layer is a majority leukocytes and the second layer is a majority thrombocytes.
Type:
Application
Filed:
October 21, 2021
Publication date:
April 21, 2022
Applicant:
REAPPLIX A/S
Inventors:
Rasmus LUNDQUIST, Niels Erik HOLM, Morten Rosenberg Eskildsen
Abstract: A method for treating surgical wounds uses a blood product having a first layer, and a second layer, the first layer being adjacent to the second layer, the first layer defining a first outer surface of the blood product, the first layer having a majority of leukocytes and the second layer having a majority of thrombocytes. The method improves the healing or the wound and reduces the formation of scars.
Type:
Application
Filed:
October 21, 2021
Publication date:
April 21, 2022
Applicant:
REAPPLIX A/S
Inventors:
Rasmus LUNDQUIST, Niels Erik HOLM, Morten Rosenberg ESKILDSEN